$75.53 -0.93 (%) Eli Lilly & Co - New York Stock Exchange, Inc.

Apr. 29, 2016 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Top Funds Heart Edward Lifesciences, Bump Lilly

    IBD | Feb. 5, 2016 | 14:27PM EST
  2. Merck Stock Slides As Q4 Revenue, Guidance Miss Expectations

    IBD | Feb. 3, 2016 | 11:44AM EST
  3. Earnings Recap For January 28

    Benzinga | Jan. 28, 2016 | 16:34PM EST
  4. Eli Lilly Punished For Inline Report

    Benzinga | Jan. 28, 2016 | 11:34AM EST
  5. JNJ Kicks Off Health Care Earnings—What About Deals, Buybacks?

    Benzinga | Jan. 25, 2016 | 11:43AM EST
  6. Stock Marquee Crowded With Oil, Apple, and the Fed

    Benzinga | Jan. 25, 2016 | 10:25AM EST
  7. Last-Hour Rally Erases Midday Losses As Indexes Close Mixed

    IBD | Jan. 19, 2016 | 16:49PM EST
  8. Steven Cohen Makes Eli Lilly, Kraft Heinz Top New Buys

    GuruFocus | Jan. 7, 2016 | 13:14PM EST
  9. A Calmer Year For Pharma?

    IBD | Jan. 6, 2016 | 18:47PM EST
  10. 3 Potential Blockbuster Drugs Launching in 2016

    IBD | Jan. 6, 2016 | 09:42AM EST
  11. Lilly Counts On Pipeline In '16

    IBD | Jan. 5, 2016 | 18:56PM EST
  12. Lilly Guidance Misses Estimates On Lower Sales

    IBD | Jan. 5, 2016 | 13:18PM EST
  13. The 5 Top-Performing Big-Cap Drug Stocks Of 2015

    IBD | Dec. 30, 2015 | 14:16PM EST
  14. 5 Top Stocks of the Outperforming Vanguard Health Care Fund

    GuruFocus | Dec. 24, 2015 | 15:44PM EST
  15. Mairs and Power Sells Baxalta, Walt Disney, Target

    GuruFocus | Dec. 16, 2015 | 16:08PM EST
  16. Strategic Beta ETFs Among Year's Top Performers

    IBD | Dec. 15, 2015 | 19:12PM EST
  17. Benzinga's Top Upgrades

    Benzinga | Dec. 7, 2015 | 08:59AM EST
  18. GoPro PT Cut; Chipotle, Bluebird Bio Downgraded

    IBD | Dec. 7, 2015 | 08:56AM EST
  19. Cautious Stock Rebound as Jobs Data Delivers But Wages Still in Question

    Benzinga | Dec. 4, 2015 | 10:46AM EST
  20. Lilly Ends Basal Insulin Peglispro Development Program

    Benzinga | Dec. 4, 2015 | 08:00AM EST
  21. HOTCHKIS & WILEY Buys More Than 7 Million Shares in Oil and Gas Company

    GuruFocus | Dec. 2, 2015 | 18:44PM EST
  22. Merck

    IBD | Dec. 1, 2015 | 18:47PM EST
  23. 3 Big Pharma Upgrades (And One Downgrade) At Barclays

    IBD | Dec. 1, 2015 | 15:31PM EST
  24. Amazon's PT Raised; Yum, J&J, Merck, Lilly Upgraded

    IBD | Dec. 1, 2015 | 09:15AM EST
  25. Benzinga's Top Upgrades

    Benzinga | Dec. 1, 2015 | 08:55AM EST
  26. Sanofi Chipping Away At Biogen's MS Dominance

    IBD | Nov. 30, 2015 | 11:32AM EST
  27. Steven Cohen Hikes Stake in Microsoft by More Than 50,000%

    GuruFocus | Nov. 27, 2015 | 18:01PM EST
  28. Biotechs Weaken, But These Names Have Bullish Charts

    IBD | Nov. 25, 2015 | 17:19PM EST
  29. Eli Lilly Release Confirms FDA Approval If Portrazza

    Benzinga | Nov. 24, 2015 | 14:44PM EST
  30. Lilly and Merck Expand Immuno-oncology Collaboration with Phase III Nonsquamous Non-Small Cell Lung Cancer Trial

    Benzinga | Nov. 19, 2015 | 06:33AM EST
  31. Goldman Sachs' Top 4 Smid-Cap Biotech Picks

    IBD | Nov. 18, 2015 | 15:36PM EST
  32. PRIMECAP Sells Stake in Technology Company

    GuruFocus | Nov. 16, 2015 | 17:04PM EST
  33. Benzinga's Top Upgrades

    Benzinga | Nov. 16, 2015 | 08:54AM EST
  34. ELI LILLY

    IBD | Nov. 10, 2015 | 18:47PM EST
  35. Lilly, Incyte Announce Data Demonstrate Baricitinib Superiority to Adalimumab in Improving Signs and Symptoms of RA

    Benzinga | Nov. 7, 2015 | 20:04PM EST
  36. DOJ Eyes Lilly, Merck Pricing

    IBD | Nov. 6, 2015 | 18:57PM EST
  37. How This Top Stock Mutual Fund Manager Seeks Growth

    IBD | Nov. 4, 2015 | 18:43PM EST
  38. How This Top Stock Mutual Fund Manager Seeks Growth

    IBD | Nov. 3, 2015 | 18:43PM EST
  39. Sanofi, Novo Nordisk Slide On Diabetes Headwinds

    IBD | Oct. 29, 2015 | 12:40PM EST
  40. Lilly and Incyte Announce Webcast to Discuss Baricitinib Phase 3 Data

    Benzinga | Oct. 27, 2015 | 13:20PM EST
  41. Eli Lilly Q3 Earnings, Guidance Beat On Cost Control

    IBD | Oct. 22, 2015 | 12:36PM EST
  42. Eli Lilly CEO: Our Drug Prices are Fair

    FoxBusiness | Oct. 22, 2015 | 10:28AM EST
  43. McDonald's Strong 3Q Helps Wall Street Jump

    FoxBusiness | Oct. 22, 2015 | 08:15AM EST
  44. Eli Lilly Posts Upbeat Q3 Earnings, Raises Forecast

    Benzinga | Oct. 22, 2015 | 06:55AM EST
  45. Eli Lilly Reports Mixed 3Q Results

    FoxBusiness | Oct. 22, 2015 | 06:29AM EST
  46. Lilly supports global Dementia Discovery Fund

    Benzinga | Oct. 21, 2015 | 06:34AM EST
  47. Wal-Mart's $21 Billion Loss Lost on NYSE Officials

    FoxBusiness | Oct. 14, 2015 | 18:39PM EST
  48. Lilly-Incyte drug beats Humira

    IBD | Oct. 14, 2015 | 18:35PM EST
  49. Lilly-Incyte Drug Beats Humira In Arthritis Trial

    IBD | Oct. 14, 2015 | 11:12AM EST
  50. US Stock Futures Down; JPMorgan Earnings In Focus

    Benzinga | Oct. 13, 2015 | 07:31AM EST
Trading Center